$7.940
-0.128 (-1.61%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BCRX por análisis de gráficos similares
Alphio's BCRX stock price prediction model matches the current BioCryst Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.07 (+1.64%). The 1-week path is $8.14 (+2.57%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals Inc (BCRX) is currently trading at $7.79, which is below the average analyst price target of $12 to $13, indicating potential upside. However, the stock has a low RSI of 27.65, suggesting it is oversold, but recent performance shows a 5-day decline of 8.89%, reflecting negative sentiment. The main risk is the downgrade by RBC, which has lowered its price target to $11 due to competitive pressures affecting revenue from Orladeyo, which is projected to drop to $400 million to $450 million in the long term. Therefore, while there is potential for recovery, the current market conditions and analyst sentiment suggest holding rather than buying at this moment.
BCRX cerró en $7.94 el Tuesday, tras bajar -1.61%
BioCryst Pharmaceuticals, Inc. (BCRX) last closed at $7.94, losing -1.61%. These facts feed the 1-day and 1-week BCRX price prediction above.
Factores de la previsión
Los factores de la previsión de BioCryst Pharmaceuticals, Inc. (BCRX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BCRX, ordenadas por similitud.
Análisis de estacionalidad de BCRX
Historically the probability of a positive October return for BCRX is 61.67%. July offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BCRX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $16.05 | $16.54 | $19.80 | +108.33% |
| Nov 2026 | $12.53 | $14.03 | $16.10 | +76.71% |
| Dec 2026 | $15.40 | $17.17 | $18.22 | +116.22% |
En 2026, se proyecta que BioCryst Pharmaceuticals, Inc. (BCRX) oscile entre $12.53 y $19.80.
Previsión mensual de BioCryst Pharmaceuticals, Inc. para 2026
En Oct de 2026, se proyecta que BioCryst Pharmaceuticals, Inc. promedie $16.54, con un mínimo de $16.05 y un máximo de $19.80.
En Nov de 2026, se proyecta que BioCryst Pharmaceuticals, Inc. promedie $14.03, con un mínimo de $12.53 y un máximo de $16.10.
En Dec de 2026, se proyecta que BioCryst Pharmaceuticals, Inc. promedie $17.17, con un mínimo de $15.40 y un máximo de $18.22.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.